Cytopathology

Diffuse optics for diagnosticsDiffuse optics for diagnostics

Among the optics-based tools used in diagnostics, diffuse optics (DO) is rapidly emerging as one of the most attractive technologies.

Clinical andrology: overcoming barriers, improving outcomes

Clinical Scientist and Andrology Service Lead Stuart Long on the impact that taking on a patient-facing role can have.

Acute lymphoblastic leukaemia

Lecturer in Biomedical Science at the University of Salford Tahmina Hussain looks at leukaemia and presents a case study.

Four days in March: An advisory view of congress

With Congress fast approaching, Brian Nation, IBMS Editorial Specialist Advisor, looks at a few programme highlights of the forthcoming biennial event at the International Convention Centre in Birmingham next March.

Decreased testing could lead to STI surge

Screening and testing for sexually transmitted infections (STIs) in the US decreased by 63% for men and 59% for women during the early months of the pandemic.

Rise of the resistance

Kip Heath, Lead Healthcare Scientist, Public Engagement Lead and stand-up comedian, introduces a project to raise public awareness of antimicrobial resistance.

My lab: a whole new approach to assessment

Leslie Ramos, Cellular Pathology Quality Manager, gives a guided tour of her lab and talks through a recent virtual UKAS assessment.

Avoidable cancer delays

One in four cancer patients experienced a delay to their diagnosis that could have been avoided, according to a new study by Cancer Research UK.

Diagnosing brain cancer

A blood test which could help to accelerate the diagnosis of brain cancer has been developed.

November news in numbers

A breakdown of science news this month, in numbers.

New cancer-driving mutation

Scientists have discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome, also known as the “dark matter” of human cancer DNA.

Top